↓ Skip to main content

Results from a Nationwide Cohort Temporary Utilization Authorization (ATU) Survey of Patients in France Treated with Pheburane® (Sodium Phenylbutyrate) Taste-Masked Granules

Overview of attention for article published in Pediatric Drugs, June 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#8 of 580)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
4 news outlets
policy
1 policy source
patent
3 patents

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
27 Mendeley
Title
Results from a Nationwide Cohort Temporary Utilization Authorization (ATU) Survey of Patients in France Treated with Pheburane® (Sodium Phenylbutyrate) Taste-Masked Granules
Published in
Pediatric Drugs, June 2014
DOI 10.1007/s40272-014-0081-5
Pubmed ID
Authors

Yves Kibleur, Dries Dobbelaere, Magalie Barth, Anaïs Brassier, Nathalie Guffon

Abstract

The aim of this study was to describe a nationwide system for pre-marketing follow-up (cohort temporary utilization authorization [ATU] protocol; i.e., 'therapeutic utilization') of a new taste-masked formulation of sodium phenylbutyrate (NaPB) granules (Pheburane(®)) in France and to analyze safety and efficacy in this treated cohort of patients with urea cycle disease (UCD).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 22%
Student > Master 5 19%
Student > Ph. D. Student 4 15%
Student > Bachelor 2 7%
Researcher 2 7%
Other 1 4%
Unknown 7 26%
Readers by discipline Count As %
Medicine and Dentistry 9 33%
Pharmacology, Toxicology and Pharmaceutical Science 3 11%
Agricultural and Biological Sciences 2 7%
Nursing and Health Professions 1 4%
Social Sciences 1 4%
Other 3 11%
Unknown 8 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 36. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2024.
All research outputs
#1,092,669
of 25,214,112 outputs
Outputs from Pediatric Drugs
#8
of 580 outputs
Outputs of similar age
#10,509
of 234,616 outputs
Outputs of similar age from Pediatric Drugs
#1
of 8 outputs
Altmetric has tracked 25,214,112 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 580 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 234,616 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them